Insidevaccines is three months old today. In three months our team of writers, editors and proofreaders have put together 23 articles. In the days just before our opening on February 1st we also compiled 22 pages of useful information on a wide variety of vaccine related topics. We have linked to published scientific papers, to the Centers for Disease Control and to manufacturer’s product inserts.
We would like to thank all of the people who have spread links to insidevaccines across the web, with special thanks to Sandy Gottstein of Vaccination News and Ginger Taylor of Adventures in Autism for adding our link to their sites.
Disclaimer: Insidevaccines, although it is three months old, has not yet received any of the CDC recommended vaccines. Enter at your peril!
The Vaccine Adverse Event Reporting System (VAERS) is currently the only method of post-licensure surveillance for adverse reactions to vaccines in the United States. VAERS is a passive reporting system that allows physicians and parents to submit reports of potential adverse events post-vaccination. Unlike the mandatory reporting system for vaccine preventable diseases, there is no mandated system for the reporting of adverse events following vaccination. The FDA and CDC utilize VAERS for identifying adverse events associated with licensed vaccines (Chen, Rastogi, & Mullen, et al., 1994). Rosenthal and Chen (1995) note that vaccine trials “have sample sizes that are insufficient to detect rare adverse events” and “are usually carried out in well-defined, homogeneous populations with relatively short follow-up periods which may limit their generalizability (p.1706)”. Therefore, it can be assumed that accurate reporting of adverse events to VAERS is a critical issue in indentifying adverse events that occur in the general population. Unfortunately, current literature suggests that VAERS is, at best, poorly utilized (Rosenthal & Chen, 1995).
Welcome to Inside Vaccines. Please let us know what you think of our articles. We welcome feedback and will be happy to respond to your concerns. Our focus will be on the science of vaccines and the social context of vaccination and we are happy to entertain ideas for articles on any relevant topic.
Thank you for your interest.